Microfluidic Artificial Cells for Uniform Single-Cell Mass Spectrometry

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for preparing artificial cells for single-cell mass spectrometry (SCMS) measurement lack uniformity and stability, leading to inaccurate and unreliable results due to polydispersed liposomes and poor encapsulation efficiency, which complicates the reproducibility and comparability of SCMS measurements across different samples.

Innovation Solution

A microfluidic platform is used to create a double-emulsion liposome-derived artificial cell with a specific composition of polyethylene glycol (PEG), polyvinyl alcohol (PVA), and L-α-phosphatidylcholine, allowing for controlled preparation of uniform and stable artificial cells through a three-phase channel system, enabling batch production and precise encapsulation of target compounds.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional methods are used to prepare artificial cells, then the preparation process is simple, but the uniformity and stability of the artificial cells are poor

Engineering Contradiction:
Improveuniformity of artificial cellsVSAvoidcomplexity of preparation system
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent introduces a microfluidic device as an intermediary system between conventional preparation methods and the desired uniform artificial cells. This device mediates the preparation process by providing controlled mixing, droplet generation, and encapsulation environments, thereby achieving high uniformity without requiring overly complex manual procedures

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent replaces manual mechanical preparation methods with a microfluidic-based automated system. The microfluidic device uses fluid dynamics and controlled flow fields to achieve precise encapsulation and uniform cell formation, substituting complex manual mechanical operations with a more controllable fluid-based system

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Reliability

If polydispersed liposomes are used in artificial cells, then the preparation is easier, but the stability and reliability of SCMS measurements deteriorate

Engineering Contradiction:
Improvereliability of SCMS measurementsVSAvoidease of artificial cell preparation
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent changes key preparation parameters including liposome size distribution control, encapsulation concentration, and microfluidic flow rates to achieve monodisperse artificial cells. By precisely controlling these parameters, the system produces highly reliable SCMS measurement samples while maintaining reasonable preparation ease through systematic parameter optimization

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent applies local quality control by ensuring uniform distribution of target compounds within each artificial cell and maintaining consistent liposome properties throughout the preparation. This localized control of quality attributes (encapsulation efficiency, size uniformity, compound distribution) enhances measurement reliability without requiring complete overhaul of the preparation process

Inventive Principle:
Principle #3Local quality

3Reliability

If natural single cells are used for SCMS measurement, then the biological authenticity is high, but the individual differences and instability are significant

Engineering Contradiction:
Improvestability of measurement resultsVSAvoidbiological authenticity of samples
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent creates artificial cell copies that replicate the essential structural and functional characteristics of natural cells without the biological variability. These synthetic models copy the relevant features (membrane structure, encapsulated compounds, size distribution) needed for SCMS measurement while eliminating individual differences, thereby achieving stable and reliable measurements

Inventive Principle:
Principle #26Copying

4Measurement precision

If encapsulation efficiency is low in artificial cells, then the preparation process is simpler, but the accuracy of SCMS measurements decreases

Engineering Contradiction:
Improveaccuracy of SCMS measurementsVSAvoidcomplexity of encapsulation system
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The microfluidic device serves as an intermediary encapsulation system that achieves high encapsulation efficiency through controlled droplet formation and coalescence. The device mediates the interaction between liposomes and target compounds, ensuring efficient encapsulation while maintaining a relatively simple overall preparation workflow

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent replaces traditional mechanical mixing and encapsulation methods with microfluidic-based droplet generation and fusion techniques. This substitution achieves superior encapsulation efficiency through precise control of fluid interfaces and droplet coalescence, while the automated nature of the system keeps operational complexity manageable

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves highly uniform, stable, and controllable artificial cells that improve the accuracy and reliability of SCMS measurements by minimizing individual sample differences and providing standardizable reference materials, enhancing the reproducibility and comparability of results.

Implementation Method 1

A microfluidic platform is used to create a double-emulsion liposome-derived artificial cell

Methodology Applied
Scientific EffectEmulsion: Emulsion

Implementation Method 2

liposomes are generally composed of naturally-synthesized phospholipid bilayers or vesicles prepared from artificial self-assembled materials

Methodology Applied
Scientific EffectSelf-Assembly: Self-Assembly

Data Source

PatentUS20240420940A1Artificial cell for single-cell mass spectrometry (SCMS) measurement and preparation method thereof
Publication Date: 2024.12.19 NATIONAL INSTITUTE OF METROLOGY CHINA
  • US20240420940A1 patent drawing
  • US20240420940A1 patent drawing
  • US20240420940A1 patent drawing

AI summary

The present disclosure provides an artificial cell for single-cell mass spectrometry (SCMS) measurement and a preparation method thereof. In the present disclosure, the artificial cell includes an internal aqueous phase, an intermediate oil phase, and an external aqueous phase; where the internal aqueous phase includes polyethylene glycol (PEG) and a polyvinyl alcohol (PVA) aqueous solution, and the intermediate oil phase includes a chloroform-hexane mixture of L-α-phosphatidylcholine; and the external aqueous phase includes PVA and an F-68 aqueous solution. Compared with natural cell samples, new artificial single cells based on microfluidic self-assembly provided by the present disclosure have better uniformity, stability, and controllability. The artificial cell can effectively avoid significant measurement differences between individual single-cell samples, and effectively solve the problem of difficulty in stably preserving biological samples.